Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 9:31 PM
Ignite Modification Date: 2025-12-24 @ 9:31 PM
NCT ID: NCT02268032
Eligibility Criteria: Inclusion Criteria: 1. Women between 38 and 45 years of age who have not used hormonal contraceptive methods at least for the past two months, or who have been surgically sterilized, with no contraindications for androgenic therapy. 2. Women with preserved menstrual cycles. 3. Women smoking less than 5 cigarettes daily. 4. Anti-Müllerian hormone (AMH) between 0.5-1.1 ng/mL 5. Total antral follicle count (AFC) 5-7 Exclusion Criteria: 1. Women receiving medications that interact with DHEA metabolism (Anastrozole, exemestane, Fulvestrant, Insulin, Letrozole, Tamoxifen, Triazolam). 2. Women with diabetes mellitus 3. Women with untreated or decompensated endocrine disorders 4. Women with a prior history of ovarian surgery or oophorectomy
Healthy Volunteers: True
Sex: FEMALE
Minimum Age: 38 Years
Maximum Age: 45 Years
Study: NCT02268032
Study Brief:
Protocol Section: NCT02268032